Factor XI inhibitors: cardiovascular perspectives

R De Caterina, D Prisco… - European Heart …, 2023 - academic.oup.com
Anticoagulants are the cornerstone for prevention and treatment of thrombosis but are not
completely effective, and concerns about the risk of bleeding continue to limit their uptake …

Factor XI inhibitors: cardiovascular perspectives.

RD Caterina, D Prisco… - European Heart …, 2023 - search.ebscohost.com
Anticoagulants are the cornerstone for prevention and treatment of thrombosis but are not
completely effective, and concerns about the risk of bleeding continue to limit their uptake …

Factor XI inhibitors: cardiovascular perspectives

R De Caterina, D Prisco… - European heart …, 2023 - pubmed.ncbi.nlm.nih.gov
Anticoagulants are the cornerstone for prevention and treatment of thrombosis but are not
completely effective, and concerns about the risk of bleeding continue to limit their uptake …

[引用][C] Factor XI inhibitors: cardiovascular perspectives

R De Caterina, D Prisco, JW Eikelboom - EUROPEAN HEART …, 2022 - flore.unifi.it
Factor XI inhibitors: cardiovascular perspectives IRIS IRIS Home Sfoglia Macrotipologie &
tipologie Autore Titolo Riviste Serie IT Italiano Italiano English English LOGIN 1.FLORE 2.Catalogo …

Factor XI inhibitors: cardiovascular perspectives

R De Caterina, D Prisco… - European Heart …, 2023 - academic.oup.com
Anticoagulants are the cornerstone for prevention and treatment of thrombosis but are not
completely effective, and concerns about the risk of bleeding continue to limit their uptake …

Factor XI inhibitors: cardiovascular perspectives.

R De Caterina, D Prisco, JW Eikelboom - European Heart Journal, 2022 - europepmc.org
Anticoagulants are the cornerstone for prevention and treatment of thrombosis but are not
completely effective, and concerns about the risk of bleeding continue to limit their uptake …